Cargando…
A Criterion-based Approach for the Systematic and Transparent Extrapolation of Clinical Trial Survival Data
Background: Trial data often does not cover a sufficiently long period of time to truly capture time-toevent endpoints, however, Health Technology Assessment (HTA) bodies often require overall survival (OS) and progression-free survival (PFS) estimates. Often, significant survival effects are found...
Autores principales: | Tremblay, Gabriel, Haines, Patrick, Briggs, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia Data Analytics, LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471402/ https://www.ncbi.nlm.nih.gov/pubmed/37663587 http://dx.doi.org/10.36469/9896 |
Ejemplares similares
-
Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer
por: Tremblay, Gabriel, et al.
Publicado: (2016) -
Secondary Use of Data: Non-Interventional Study Best Practices in Planning and Protocol Development
por: Fang, Juanzhi, et al.
Publicado: (2017) -
A Characterisation and Profiling of District Health Indicators in Zimbabwe: An Application of Principal Component Analysis in a Data Limited Setting
por: Shamu, Shepherd, et al.
Publicado: (2015) -
Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data immaturity
por: Heeg, Bart, et al.
Publicado: (2023) -
No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients
por: Pyenson, Bruce S., et al.
Publicado: (2019)